Bristol-Myers Squibb Company (BMY) is a Healthcare · Drug Manufacturers - General company listed on NYSE. Price $63.06 (+0.35%), Market cap $121.42B, P/E ratio 16.66, 52-week low–high $42.60 ~ $62.37.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metast
Financial statements, price targets, institutional (13F) holdings and related news for Bristol-Myers Squibb Company are updated in real time on BlackAll Trade.
Bristol-Myers Squibb Company trades at $63.06 (+0.35%). Real-time quotes and charts are available on BlackAll Trade.
Bristol-Myers Squibb Company has a market cap of about $121.42B. Its P/E ratio is 16.66.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology,